Krensavage Asset Management, LLC Q4 2025 Filing

Filed February 18, 2026

Portfolio Value

$283.1M

Holdings

18

Report Date

Q4 2025

Filing Type

13F-HR

All Holdings (18 positions)

#StockSharesValue% PortfolioType
1
UTHUNITED THERAPEUTICS CORP
91,282$44.5M15.71%
2
ENTAENANTA PHARMACEUTICALS INC
2,766,390$43.6M15.41%
3
BMRNBIOMARIN PHARMACEUTICAL INC
524,786$31.2M11.02%
4
JAZZJAZZ PHARMACEUTICALS PLC
167,816$28.5M10.08%
5
EX9EXELIXIS INC
493,526$21.6M7.64%
6
AVDLAVADEL PHARMACEUTICALS
855,860$18.4M6.51%
7
SNYSANOFI-ADR
323,946$15.7M5.54%
8
SUPNSUPERNUS PHARMACEUTICALS INC
313,499$15.6M5.50%
9
CAHCARDINAL HEALTH INC
73,745$15.2M5.35%
10
INDIVIOR PLC
339,532$12.2M4.30%
11
VNDAVANDA PHARMACEUTICALS INC
1,180,388$10.4M3.68%
12
BNTXBIONTECH SE-ADR
99,523$9.5M3.35%
13
GSKGSK PLC-SPON ADR
96,729$4.7M1.68%
14
RAREULTRAGENYX PHARMACEUTICAL IN
149,634$3.4M1.22%
15
REGNREGENERON PHARMACEUTICALS
4,000$3.1M1.09%
16
ALKSALKERMES PLC
107,822$3.0M1.07%
17
BIIBBIOGEN INC
10,000$1.8M0.62%
18
EOLSEVOLUS INC
100,000$665K0.23%